BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17285763)

  • 1. Frequency analysis of apoptosis in sporadic breast cancer.
    Kozłowska E; Smolarz B; Kulig A; Romanowicz-Makowska H
    Pol J Pathol; 2006; 57(4):199-204. PubMed ID: 17285763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analysis of apoptosis in breast and ovarian cancer subjects--genetic studies.
    Kozłowska E; Romanowicz-Makowska H; Zadrozny M; Mankiewicz J; Szyłło K; Pertyński T; Kulig A; Smolarz B
    Pol J Pathol; 2003; 54(1):25-9. PubMed ID: 12817877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
    Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
    Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased apoptosis in non-involved tissue from cancer-containing breasts.
    Hassan HI; Walker RA
    J Pathol; 1998 Mar; 184(3):258-64. PubMed ID: 9614377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In situ observation of apoptosis and proliferation in breast cancer and its precancerous lesions].
    Sun S; Li L; Sun D
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):447-9. PubMed ID: 11776623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of anti-apoptotic proteins in non-involved tissue from cancer-containing breasts.
    Batchelder AJ; Gordon-Weeks AN; Walker RA
    Breast Cancer Res Treat; 2009 Mar; 114(1):63-9. PubMed ID: 18368476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Hasnan J; Rusli J; Kamal Y; Imran AK; Ahmed M; Zakaria J
    Singapore Med J; 2007 Jul; 48(7):607-14. PubMed ID: 17609820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis and production of TNF-alpha by tumor-associated inflammatory cells in histological grade III breast cancer.
    Estevam FR; Augusto SF; Rodrigues SA; Pinheiro MR; Monteiro AF
    Cancer Immunol Immunother; 2005 Jul; 54(7):671-6. PubMed ID: 15625605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma.
    Sanlioglu AD; Korcum AF; Pestereli E; Erdogan G; Karaveli S; Savas B; Griffith TS; Sanlioglu S
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):716-23. PubMed ID: 17512128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of necrosis in Nigerian breast cancer.
    Ikpatt O; Ndoma-Egba R; Collan Y
    Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in invasive ductal breast cancer: different behavior in high and minimum hormone-receptive cancers.
    della Rovere F; Granata A; Familiari D; D'Arrigo G; Mondello B; Basile G
    Anticancer Res; 2007; 27(4B):2465-71. PubMed ID: 17695540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of BRCA1 gene mutations and apoptosis phenomenon in sporadic breast cancer.
    Romanowicz-Makowska H; Smolarz B; Zadrozny M; Stetkiewicz T; Sobczuk A; Przybyłowska K; Kulig A
    Pol J Pathol; 2005; 56(3):111-4. PubMed ID: 16334977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extent of destructive changes in tumor parenchyma of breast cancer patients of various age].
    Kriuchkov AN
    Vopr Onkol; 2007; 53(5):531-4. PubMed ID: 18154115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ; Simpson PT; Da Silva L; Jayanthan J; Reid L; Lakhani SR; Rosen PP
    Am J Surg Pathol; 2009 Apr; 33(4):496-504. PubMed ID: 19047897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial cell turnover, p53 and bcl-2 protein expression during oncogenesis of early and advanced gastric cancer in a Western population.
    Triantafyllou K; Kitsanta P; Karamanolis DG; Kittas C; Ladas SD
    Dig Liver Dis; 2008 Jan; 40(1):39-45. PubMed ID: 18063429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.